Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Levels in Adolescent with Bipolar Disorder and Their Relationship with Metabolic Parameters
- 23 March 2022
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 72 (6) , 1313-1321
Abstract
Peroxisome proliferator-activated receptor gamma (PPARγ) is one of the immune and metabolic regulatory agents. This study examined the serum PPARγ levels and metabolic syndrome (MetS) parameters in pediatric bipolar disorder (PBD) adolescents and compared them with healthy subjects. Serum PPARγ levels, fasting blood glucose (FBG), high-density lipoprotein cholesterol (HDL-C), triglycerides (TG), and fasting insulin levels of 39 PBD-type I (age range: 14–18) and 36 age- and sex-matched healthy control subjects were compared. The anthropometric measurements were also analyzed, including body weight, height, body mass index (BMI), waist circumference (WC), and blood pressure measurements. The PPARγ levels were significantly lower, and the MetS prevalence was significantly higher in the PBD group than in the control group. The mean BMI, WC, serum TG, and FBG values of the PBD group were statistically higher than the healthy control group. There was no significant relationship between the PPARγ levels and metabolic parameters except fasting glucose. Lower PPARγ activity and higher MetS prevalence in PBD indicate dysregulation of immune and metabolic regulatory parameters. These results may shed light on developing new PBD medications.Keywords
This publication has 46 references indexed in Scilit:
- Prevalence of Metabolic Syndrome and Obesity in Adolescents Aged 12 to 19 Years: Comparison between the United States and KoreaJournal of Korean Medical Science, 2010
- Can body mass index help predict outcome in patients with bipolar disorder?Bipolar Disorders, 2009
- Psychosocial functioning among bipolar youthJournal of Affective Disorders, 2009
- Neuronal Peroxisome Proliferator-Activated Receptor γ Signaling: Regulation by Mood-Stabilizer ValproateJournal of Molecular Neuroscience, 2008
- Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 1Schizophrenia Research, 2008
- PPARs in the brainBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2007
- Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug useJournal of Affective Disorders, 2002
- Serological observations in patients suffering from acute manic episodesHuman Psychopharmacology: Clinical and Experimental, 2002
- Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferatorsNature, 1990
- A Rating Scale for Mania: Reliability, Validity and SensitivityThe British Journal of Psychiatry, 1978